D(4) dopamine receptor
| GO Term | Evidence Code | Reference |
|---|---|---|
| behavioral fear response | ||
| response to amphetamine | ||
| intracellular calcium ion homeostasis | ||
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | ||
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| dopamine neurotransmitter receptor activity, coupled via Gi/Go | ||
| dopamine neurotransmitter receptor activity, coupled via Gi/Go | ||
| dopamine neurotransmitter receptor activity, coupled via Gi/Go | ||
| dopamine neurotransmitter receptor activity, coupled via Gi/Go | ||
| dopamine neurotransmitter receptor activity |
| Pathway Name | Organism |
|---|---|
| Dopamine receptors | Homo sapiens |
| G alpha (i) signalling events | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:4428 | dyslexia | |
| DOID:11206 | opioid abuse | |
| DOID:302 | substance abuse | |
| DOID:10939 | antisocial personality disorder | |
| DOID:5082 | liver cirrhosis | |
| DOID:1059 | intellectual disability | |
| DOID:1574 | alcohol use disorder | |
| DOID:0050742 | nicotine dependence | |
| DOID:12995 | conduct disorder | |
| DOID:12399 | pathological gambling |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026